Technical Paper Series - Intoxication launched
Seeing Machines Limited has launched a new technical paper series focused on non-fatigue driver impairment, beginning with alcohol intoxication, aiming to complement existing roadside testing with in-vehicle detection capabilities. The company's Driver Monitoring System (DMS) technology is being developed to assess functional impairment in real-time, addressing the limitations of solely relying on Blood Alcohol Concentration (BAC) readings. This initiative, supported by collaborations with experts and universities, seeks to provide enhanced safety protections by reflecting real-world risks associated with intoxication and other drug influences.
Select text to share a quote on X · sign in to keep highlights & notes in your SEE notes
Alcohol-related driver impairment remains a key factor in road accidents globally as current roadside strategies don't go far enough
Canberra, 17 December 2025: Seeing Machines Limited, a global leader in vision-based monitoring technology, has released Part One of its new Technical Paper series, dedicated to advancing the understanding and detection of non-fatigue driver impairment, starting with intoxication. This initiative marks a major step in the company's broader focus on leveraging its Driver Monitoring System (DMS) technology to address critical safety challenges on roads, globally.
Alcohol continues to be a leading cause of road trauma worldwide, contributing significantly to fatalities and injuries despite ongoing roadside based preventative efforts. Recognising these persistent risks, Seeing Machines has launched its capability to harness the power of DMS technology to identify impairment from alcohol in real time.
The Company's latest research highlights the limitations of relying solely on Blood Alcohol Concentration (BAC) as a benchmark for impairment. Traditional approaches often overlook the way impairment unfolds over time, resulting in gaps between BAC progression and real-world driver performance. Seeing Machines' DMS technology aims to bridge this divide by directly assessing functional impairment in real time, ensuring enhanced detection sensitivity and more effective in-cabin intervention strategies.
"Roadside alcohol testing has delivered great reductions in road injury over many years. Our goal is to complement these existing roadside programs by leading the introduction of in-vehicle approaches," said Dr Mike Lenné, Chief Safety Officer at Seeing Machines. "By incorporating the temporal dynamics of impairment, how it evolves during both the ascending and descending phases of intoxication from alcohol as well as the complex effects of other drugs such as cannabis, our technology can reflect real-time real-world risks and provide greater safety protections to road users."
To support this approach, Seeing Machines is working with leading experts and universities, conducting pioneering experiments that explore the disconnect between BAC readings and actual driver impairment. These collaborations underscore the Company's commitment to developing solutions that align technological innovation with real-world safety outcomes.
Part One of the Technical Paper series is now available, with future instalments set to explore additional aspects of non-fatigue impairment, including from cannabis, and further enhance the capabilities of DMS technology for road safety.
Click here for Part One: https://seeingmachines.com/technical-paper-series-intoxication
About Seeing Machines (LSE: SEE)
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.